Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals?

被引:0
作者
Narva, Sara [1 ,2 ,7 ,8 ]
Polo-Kantola, Paivi [1 ,2 ]
Oksa, Sinikka [3 ]
Kallio, Johanna [2 ,4 ,7 ]
Huvila, Jutta [2 ,5 ,7 ]
Rissanen, Tiia [2 ,6 ]
Hynninen, Johanna [1 ,2 ,7 ]
Hietanen, Sakari [1 ,2 ,7 ]
Joutsiniemi, Titta [1 ,2 ,7 ]
机构
[1] Turku Univ Hosp, Dept Obstet & Gynecol, Savitehtaankatu 5, Turku 20520, Finland
[2] Univ Turku, Savitehtaankatu 5, Turku 20520, Finland
[3] Satasairaala Hosp, Dept Obstet & Gynecol, Pori, Finland
[4] Turku Univ Hosp, Dept Radiol, Turku, Finland
[5] Turku Univ Hosp, Dept Pathol, Turku, Finland
[6] Turku Univ Hosp, Dept Biostat, Turku, Finland
[7] Org EU Canc Inst, FICAN West, TYKS Canc Ctr, Turku, Finland
[8] Univ Turku, Dept Obstet & Gynecol, Turku Univ Hosp, FIN-20520 Turku, Finland
来源
EJSO | 2024年 / 50卷 / 06期
关键词
Low -risk endometrial cancer; Predictive; Surgery; Centralization; Survival; LYMPH-NODE BIOPSY; LYMPHADENECTOMY; INVASION; GRADE; MRI;
D O I
10.1016/j.ejso.2024.108317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The aim of this study was to assess the accuracy of a preoperative screening algorithm in identifying low-risk endometrial cancer (EC) patients to ensure optimal care. Methods: A total of 277 patients with primary EC confirmed through biopsy underwent magnetic resonance imaging (MRI). Patients with risk factors for advanced high-risk EC, such as non-endometrioid histology, highgrade differentiation status, deep myometrial invasion, or spread beyond the uterine corpus, were systematically excluded. The remaining preoperatively screened patients with stage IA low-grade endometrioid EC (EEC) (n = 93) underwent surgery in a tertiary hospital. The accuracy of the preoperative diagnosis was evaluated by comparing the findings with the postoperative histopathological results. Disease-free survival (DFS) and overall survival (OS) were analyzed using 8-year follow-up data. Results: Postoperative histopathological analysis revealed that all patients had grade 1-2 EEC localized to the corpus uteri. Only three patients had deep myometrial invasion (stage IB), but they remained disease-free after 6-9 years of follow-up. The median follow-up time for all patients was 8.7 years. The DFS was 7.6 years, and the OS was 8.6 years. Two patients with stage IA grade 1 EEC experienced relapse and, despite treatment, died of EC. No other EC-related deaths occurred. Conclusions: The screening algorithm accurately identified low-risk EC patients without compromising survival. Therefore, the algorithm appears to be feasible for selecting patients for surgery in secondary hospitals.
引用
收藏
页数:6
相关论文
共 37 条
  • [1] Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study
    Anic, Katharina
    Flohr, Friedrich
    Schmidt, Mona Wanda
    Krajnak, Slavomir
    Schwab, Roxana
    Schmidt, Marcus
    Westphalen, Christiane
    Eichelsbacher, Clemens
    Ruckes, Christian
    Brenner, Walburgis
    Hasenburg, Annette
    Battista, Marco Johannes
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) : 1551 - 1560
  • [2] Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
    Baker-Rand, Holly
    Kitson, Sarah J.
    [J]. CANCERS, 2024, 16 (05)
  • [3] FIGO staging of endometrial cancer: 2023
    Berek, Jonathan
    Matias-Guiu, Xavier
    Creutzberg, Carien
    Fotopoulou, Christina
    Gaffney, David
    Kehoe, Sean
    Lindemann, Kristina
    Mutch, David
    Concin, Nicole
    Endometrial Canc Staging Subcomm
    FIGO Womens Canc Comm
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 162 (02) : 383 - 394
  • [4] Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine
    Bogani, Giorgio
    Chiappa, Valentina
    Lopez, Salvatore
    Salvatore, Christian
    Interlenghi, Matteo
    D'Oria, Ottavia
    Giannini, Andrea
    Leone Roberti Maggiore, Umberto
    Chiarello, Giulia
    Palladino, Simona
    Bascio, Ludovica Spano'
    Castiglioni, Isabella
    Raspagliesi, Francesco
    [J]. HEALTHCARE, 2022, 10 (12)
  • [5] ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
    Colombo, N.
    Creutzberg, C.
    Amant, F.
    Bosse, T.
    Gonzalez-Martin, A.
    Ledermann, J.
    Marth, C.
    Nout, R.
    Querleu, D.
    Mirza, M. R.
    Sessa, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (01) : 16 - 41
  • [6] ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
    Concin, Nicole
    Matias-Guiu, Xavier
    Vergote, Ignace
    Cibula, David
    Mirza, Mansoor Raza
    Marnitz, Simone
    Ledermann, Jonathan
    Bosse, Tjalling
    Chargari, Cyrus
    Fagotti, Anna
    Fotopoulou, Christina
    Gonzalez Martin, Antonio
    Lax, Sigurd
    Lorusso, Domenica
    Marth, Christian
    Morice, Philippe
    Nout, Remi A.
    O'Donnell, Dearbhaile
    Querleu, Denis
    Raspollini, Maria Rosaria
    Sehouli, Jalid
    Sturdza, Alina
    Taylor, Alexandra
    Westermann, Anneke
    Wimberger, Pauline
    Colombo, Nicoletta
    Planchamp, Francois
    Creutzberg, Carien L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 12 - 39
  • [7] Endometrial cancer
    Crosbie, Emma J.
    Kitson, Sarah J.
    McAlpine, Jessica N.
    Mukhopadhyay, Asima
    Powell, Melanie E.
    Singh, Naveena
    [J]. LANCET, 2022, 399 (10333) : 1412 - 1428
  • [8] Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
    D'Auge, Tullio Golia
    Giannini, Andrea
    Bogani, Giorgio
    Di Dio, Camilla
    Lagana, Antonio Simone
    Di Donato, Violante
    Salerno, Maria Giovanna
    Caserta, Donatella
    Chiantera, Vito
    Vizza, Enrico
    Muzii, Ludovico
    D'Oria, Ottavia
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (08)
  • [9] Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis
    Di Donato, Violante
    Kontopantelis, Evangelos
    Cuccu, Ilaria
    Sgamba, Ludovica
    Golia D'Auge, Tullio
    Pernazza, Angelina
    Della Rocca, Carlo
    Manganaro, Lucia
    Catalano, Carlo
    Perniola, Giorgia
    Palaia, Innocenza
    Tomao, Federica
    Giannini, Andrea
    Muzii, Ludovico
    Bogani, Giorgio
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (07) : 1070 - 1076
  • [10] Recent Advances in Endometrial Cancer Management
    Di Donato, Violante
    Giannini, Andrea
    Bogani, Giorgio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)